Impact of the Gubbio population study on community control of blood pressure and hypertension

Journal of Hypertension

Volumn 19, Issue 5, 2001, Pages 843-850

  Menotti, Alessandro ^a,f   Lanti, Mariapaola ^a   Zanchetti, Alberto ^b   Puddu, Paolo Emilio ^c   Cirillo, Massimo ^d   Mancini, Mario ^d   Vagnarelli, Oscar Terradura ^e  

^a Association for Cardiac Research   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e Centro di Medicina Preventiva   (Italy)

^f Associazione per le Ricerca Cardiologica   (Italy)

Author keywords

Epidemiology; Hypertension control; Risk factors

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; COMMUNITY CARE; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL PROFESSION; POPULATION RESEARCH; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0035020155     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200105000-00002     Document Type: Article

References (21)

1. 1 Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157:2418-2446.
2. 2 Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17:151-183.
3. 3 Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whenton P, et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991. Hypertension 1995; 26:60-69.
4. 4 Colhoun HM, Dong W, Poulter NR. Blood pressure screening management and control in England: results from the health survey for England 1994. J Hypertens 1998; 16:747-752.
5. 5 Zanchetti A. How far should blood pressure be lowered? J Cardiovasc Pharmacol 1999; 84 (suppl 3):S1-S6.
6. 6 WHO Expert Committee. Hypertension control, WHO Technical Report Series no. 862. Geneva: World Health Organization.; 1996.
7. 7 Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993; 306:983-987.
8. 8 Ambrosioni E, Leonetti G, Pessina AC, Rappelli A, Trimarco B, Zanchetti A. Patterns of hypertension management in Italy: results of a pharmaco-epidemiological survey on anti-hypertensive therapy. J Hypertens 2000; 18:1691-1699.
9. 9 Laurenzi M, Trevisan M. Sodium-lithium countertransport and blood pressure: the Gubbio Population Study. Hypertension 1989; 13:408-415.
10. 10 Laurenzi M, Cirillo M, Angeletti M, Buongiorno A, Morisi G, Panarelli W, et al. on behalf of the Gubbio Population Study Research Group, Gubbio population study: baseline findings. Nutr Metab Cardiov Dis 1991 ; 1 (suppl 1):S1-S18.
11. 11 Trevisan M, Laurenzi M, on behalf of the Gubbio Collaborative Study Group. Correlates of sodium-lithium countertransport. Findings from the Gubbio Epidemiological study. Circulation 1991; 84:319-328.
12. 12 Cirillo M, Laurenzi M, Panarelli W, Trevisan M, Dyer AR, Stamler R, et al. Sodium-lithium countertransport and blood pressure changes over time: the Gubbio Study. Hypertension 1996; 27:1305-1311.
13. 13 Laurenzi M. Cirillo M, Panarelli W, Trevisan M, Stamler R, Dyer AR, et al. Baseline sodium-lithium countertransport and 6-year incidence of hypertension: the Gubbio Study. Circulation 1997; 95:581-587.
14. 14 Cirillo M, Laurenzi M, Panarelli W, Trevisan M, Stamler J, for the Gubbio Population Study Research Group. Prospective analysis of traits related to 6-year change in sodium-lithium countertransport. Hypertension 1999; 33:887-893.
15. 15 Rose G, Blackburn H. Cardiovascular survey methods. Geneva: World Health Organization; 1968.
16. 16 ISTAT. Compendio statistico Italiano, 1996. Roma: ISTAT; 1996.
17. 17 Collins R, Peto R, MacMahon S, Hebert P, Flebach NH, Eberlein KA, et al. Blood pressure, stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiologioal context. Lancet 1990; 338:827-838.
18. 18 Menotti A, Lanti M, Puddu PE. Epidemiologia delle malattie cardiovascolari. Insegnamenti dalle aree Italians del Seven Countries Study. Rome: Cardioricerca Publish; 1999.
19. 19 Menotti A, Giampaoli S, Seccareccia F. Tha relationship of cardiovascular risk factors measured at different ages to prediction of all-cause mortality and longevity. Arch Geront Geriatr 1998; 26:99-112.
20. 20 WHO MONICA Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. World Health Stat Quart 1988; 41:115-140.
21. 21 Menotti A, Seccareccia F, Lanti M, for the RIFLE Project Research Group. Mean levels and distributions of some cardiovascular risk factors in Italy in the 1970s and the 1980s. The Italian Rifle Pooling Project. Risk Factors and Life Expectancy. G Ital Cardiol 1995; 25:1539-1572.